Table 2.
sPLA2 | sPLA2 Subtype | Venom Source | Pain-Enhancing Effects | sPLA2’ Structural Determinants | Mechanisms | References |
---|---|---|---|---|---|---|
Myotoxin II | Lys-49 PLA2 | B. asper | Mechanical hyperalgesia (injected s.c., intra-articularly or around nerve) | C-terminal cationic/hydrophobic sequence 115–129 | Periphery: histamine, serotonin, sympathomimetic amines, endothelin, bradykinin, cytokines, prostaglandins; cellular influx (intraarticular injection) | [48,143] |
Spinal cord: nitric oxide, prostanoids, IL-1 and IL-6 *, astrocytes and microglia | [48,127,131] | |||||
Mechanical allodynia (injected around nerve) | ND & | Spinal cord: nitric oxide, prostanoid,; IL-1 and IL-6 *, astrocytes and microglia | [48,127] | |||
Myotoxin III | Asp-49 PLA2 | B. asper | Mechanical hyperalgesia and allodynia (injected s.c. or around nerve) | Enzymatic activity | Periphery: Bradykinin | [48] |
Spinal cord: nitric oxide, prostanoids; IL-1 and IL-6 *, astrocytes and microglia | [48,127,131] | |||||
BomoTx | Asp-49 PLA2 | B. moojeni | nonneurogenic inflammatory pain, thermal hyperalgesia, mechanical allodynia (injected s.c.) | ND & | ATP release; P2X2 and P2X3 purinergic receptors activation (mechanical sensitization), involvement of TRPV1-fibers (thermal hypernociception) | [134] |
BthTx-I | Lys-49 PLA2 | B. jararacussu | Mechanical hyperalgesia (injected s.c.) | K115; K116; R118; K122 (in the C-terminal) | ND & | [137] |
CB # | Asp-49 PLA2 | C. d. terrificus | Abdominal hyperalgesia (injected into the common bile duct) | ND & | NK1 receptors | [141] |
# basic toxic phospholipase A2 component of crotoxin, the main crotalid venom toxin; & ND: Not determined; * For the PLA2 administered around the nerve.